0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Antibody > Rabbit PAb Antibody > CD32b / Fc gamma RIIB / FCGR2B Antibody (Antigen Affinity Purified)

CD32b / Fc gamma RIIB / FCGR2B Antibody (Antigen Affinity Purified) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
80018-RP02
  YES          

CD32b / Fc gamma RIIB Antibody ( Antigen Affinity Purified ) Datasheet

  Order or Inquire for CD32b / Fc gamma RIIB Antibody product Antibody
  Detection limit is 1 ng/lane in WB
  Detection limit is 0.00975 ng/well in ELISA
 

CD32b / Fc gamma RIIB Antibody Product Information

Immunogen :

Recombinant Rat CD32b / Fc gamma RIIB protein (Catalog#80018-R08H)

Antibody Type : Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type :

Rabbit IgG

Formulation : 0.2 μm filtered solution in PBS with 5% trehalose

CD32b / Fc gamma RIIB Antibody Usage Guide

Specificity :

Rat CD32b / Fc gamma RIIB

Immunochemistry :

IHC-P: 0.1-2 μg/mL

 

ratFCGR2B-rat-liver immunohistochemistry

Immunochemical staining of rat FCGR2B in rat liver with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections). Positive staining was localized to hepatic sinusoid.
The left panel: tissue incubated with primary antibody;
The right panel: tissue incubated with the mixture of primary antibody and antigen (recombinant protein).

 

ratFCGR2B-rat-spleen immunohistochemistry    

Immunochemical staining of human FCGR2B in human kidney with rabbit polyclonal antibody (1 µg/mL, formalin-fixed paraffin embedded sections).  
Western blot : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Rat FCGR2B/CD32b in WB. Using a DAB detection system, the detection limit for Rat FCGR2B/CD32b is approximately 1 ng/lane under non-reducing conditions and reducing conditions.
Direct ELISA : This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Rat FCGR2B/CD32b. The detection limit for Rat FCGR2B/CD32b is approximately 0.00975 ng/well.
Storage : This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

CD32b / Fc gamma RIIB Antibody Related Products & Topics

Related Areas:

Proteins:

Antibodies:

CD32b / Fc gamma RIIB Antibody Background

Receptors that recognize the Fc portion of IgG (Fcγ Rs) functions in the regulation of immune response and are divided into three classes designated Fcγ RI (CD64), Fcγ RII (CD32), and Fcγ RIII (CD16). Fcγ RI binds IgG with high affinity and functions during early immune responses, whereas Fcγ RII and RIII are low affinity receptors that recognize IgG as aggregates surrounding multivalent antigens during late immune responses. Three closely related genes encodes human CD32 class by and designated Fcγ RII A, B, and C which share 94 - 99% amino acid identity in their extracellular domains. Fcγ RII B (CD32b) is expressed on cells of both myeloid and lymphoid lineages as well as on cells of non-hematopoietic origin. As the only inhibitory member in human, Fcγ RII B has an intrinsic cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM) and delivers an inhibitory signal upon ligand binding. The coordinated functioning of activating and inhibitory receptors is necessary for successful and proper initiation, amplification, and termination of immune responses, and accordingly, the Fcγ RII B plays an important negative-regulating role through modulating the signals from activation receptors. Recent study has identified CD32b expression in a variety of B-cell malignancies, suggesting that it is a potential immunotherapeutic target for B-cell lymphoproliferative disorders.

References

  1. Brooks,D.G. et al., 1989, J. Exp. Med. 170: 1369-1385.
  2. Ravetch, J. et al., 2000, Science. 290: 84-89.
  3. Takai, T., 2002, Nature Rev. Immunol. 2: 580-592.
  4. Rankin, C.T. et al., 2006, Blood. 108: 2384-2391.